AccuStem Sciences, Inc. ACUT
0.13 USD 0.00 (+0.00%)
Nov 4, 2026, 3:23 PM EST
0.13 Day range 0.13
0.117 52-week range 1.00
- YTD
- -84.02%
- 1 year
- -87.00%
- Market cap
- 2.09M
- EPS (ttm)
- -0.10
- YTD return
- -84.02%
- 1-year return
- -87.00%
- Volume
- 250
- Avg volume
- 2.67K
- Open
- 0.13
- Previous close
- 0.13
- Day's range
- 0.13 – 0.13
- 52-week range
- 0.117 – 1.00
2Y -0.1801 (-58.08%)
News
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP) 
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning 
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th 
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th 
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares 
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares 
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening 
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares 
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan 
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
Your note
Sign in to keep a note on ACUT — it syncs with the Stock Master app.